-
Somatic_mutation_profiling_of_intestinal_crypts_from_IBD_Full_STDY
Study
EGAS00001003249
-
Custom long non-coding RNA capture enhances detection sensitivity in different human sample types.
Study
EGAS00001005418
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
Exome sequencing of synchronous colorectal cancers
Study
EGAS00001003474
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
WGS of MAPKi acquired resistant samples from patients and PDX models
Study
EGAS00001006874
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Study
EGAS00001006631
-
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with Constitutional Mismatch Repair Deficiency
Study
EGAS00001007660
-
TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Study
EGAS00001002556
-
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS00001004407
-
Molecular Evolution of Cancer
Study
phs001255
-
Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma
Study
EGAS50000000060
-
Whole-genome and transcriptome versus panel sequencing in precision oncology: A translational-clinical comparison
Study
EGAS50000000431
-
Comprehensive genomic analysis of colorectal cancer with microsatellite instability
Study
JGAS000113
-
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling
Study
JGAS000243
-
Analysis of mutational and proteomic heterogeneity of gastric cancer to monitor post-treatment tumor burden using circulating tumor DNA
Study
JGAS000231
-
Treatment stratification and biomarker validation using patient-derived head and neck cancer organoids
Study
EGAS00001007076
-
RB Loss in Resistant EGFR Mutant Lung Adenocarcinomas that Transform to Small Cell Lung Cancer
Study
EGAS00001001102
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991
-
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Study
EGAS00001007029
-
CALGB/SWOG 80405: Genome-Wide Association Study of Patients with Advanced or Metastatic Colorectal Cancer Treated with First-Line Chemotherapy Combined with Cetuximab and/or Bevacizumab
Study
phs003428
-
Human Cancer-Targeted Immunity via Transgenic Hematopoietic Stem Cell Progeny
Study
phs003898
-
Single cell atlas of relapsed/refractory large B-cell lymphoma
Study
EGAS50000001293
-
Excised DNA Circles from V(D)J Recombination Promote Relapsed Leukaemia
Study
EGAS50000000407
-
Bevacizumab plus erlotinib in advanced solid cancers with Krebs cycle gene mutations: A multicenter phase II study
Study
EGAS50000001243
-
EXPRESSION OF ANTIBODY-DRUG CONJUGATE TARGETS IN BREAST CANCER METASTASES AND NORMAL TISSUE
Study
EGAS50000001334
-
Whole-genome sequencing on hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution
Study
JGAS000190
-
Molecular investigation of BCC HHI-ICI combination therapy
Study
EGAS50000001481
-
Imaging metabolic heterogeneity in breast cancer using hyperpolarized 13C-MRI
Study
EGAS00001004118
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Study
EGAS00001003306
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer RNA-Seq
Study
EGAS00001003307
-
Amplicon_based_sequencing_of_drug_resistant_lung_cancer_cell_lines
Study
EGAS00001001675
-
Cylindromas_sun_protected_and_exposed
Study
EGAS00001002521
-
Clonal architecture and genomic features of smoking versus non-smoking oncogene-driven East-Asian non-small cell lung cancer
Study
EGAS00001006942
-
Molecular Subtyping Reveals Immune Alterations Associated with Progression of Bronchial Premalignant Lesions
Study
phs003185
-
Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma
Study
phs003435
-
National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS)
Study
phs000801
-
Identifying Novel Small RNA Biomarkers Unique to Patients with Gastric Cancer
Study
phs001767
-
A Phase I Study With a Personalized Neoantigen Cancer Vaccine in Glioblastoma Multiforme
Study
phs001519
-
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients (LuCaP cell line data)
Study
EGAS50000000917
-
Development and validation of multivariate predictors of primary endocrine resistance to tamoxifen and aromatase inhibitors in luminal breast cancer reveal drug-specific differences
Study
EGAS50000001102
-
Genome and gene analysis of gastrointestinal cancer and elucidation of its clinicopathological significance
Study
JGAS000233
-
Circulating Tumor DNA in Checkpoint Inhibitor treated Lung Cancer
Study
EGAS00001004847
-
Spiradenocarcinoma
Study
EGAS00001001799
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Histone chaperone CHAF1A promotes proliferation and tumorigenicity in gastric cancer and impacts prognosis via context-depedent regulation of gene expression
Study
EGAS00001003064
-
Whole genome sequencing of a breast cancer cohort with known functional homologous recombination status
Study
EGAS00001005572
-
The University of Hong Kong Gastric Cancer Organoids RHO Signaling Study
Study
EGAS00001006252
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Genomic Analysis of Nucleic Acid Sequences from Pancreatic Cancer
Study
phs003035
-
Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study
Study
phs000879
-
Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma
Study
EGAS50000000287
-
Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors
Study
EGAS50000000642
-
Axes of Biological Variation in Diffuse Large B-Cell Lymphoma
Study
EGAS50000001227
-
Inherited damaging mutations in immune-related genes favour the development of genetically heterogeneous synchronous colorectal cancer.
Study
EGAS00001001461
-
Pseudotime_ordering_of_cell_cycle_state
Study
EGAS00001003293
-
Genetic characterization patients affected by Cancer of Unknown Primary
Study
EGAS00001006621
-
Shallow Whole Genome Sequencing of Patient Derived Xenografts
Study
EGAS50000000191
-
University of North Carolina at Chapel Hill (UNC) Hepatocellular Carcinoma Study by Exome Sequencing (HCCSES)
Study
phs000627
-
Longitudinal genome-wide analysis of progressive chronic lymphocytic leukemia under uniform front-line therapy of pentostatin, cyclophosphamide, and rituximab
Study
phs000794
-
Adoptive Cell Therapy of Autologous T cell Receptor-Engineered T Cells Targeting the p53 Neoantigens in Human Solid Tumors
Study
phs002928
-
Study of Tumor Recurrence Related to the Expression of the PAX3-FOXO1 Oncogenic Transcription Factor in Fusion-Positive Rhabdomyosarcoma
Study
phs002344
-
BPH Tissues for Cell Culture and Analysis - Spatial Transcriptomics Identifies Candidate Stromal Drivers of Benign Prostatic Hyperplasia
Study
phs003477
-
Efficacy and safety of entrectinib in patients with ROS1-positive advanced/metastatic non-small cell lung cancer (NSCLC) from the Blood First Assay Screening Trial (BFAST)
Study
EGAS50000000105
-
Cancer cell and tumor microenvironment biomarkers associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial
Study
EGAS50000000560
-
IL-27 promotes tumour control by enhancing cytotoxic T cell function
Study
EGAS50000000694
-
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-Based Cohorts (LEANORA)
Study
phs003770
-
Gene expression adaptation of metastases to their host tissue
Study
EGAS50000000817
-
Spatial transcriptomics analysis of triple negative breast cancers
Study
EGAS50000000475
-
Distinct genomic profiles and clinical outcomes in constitutional mismatch repair deficiency-associated high-grade gliomas: insights into mutational signatures and clonal evolution
Study
EGAS50000001506
-
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Study
EGAS00001000579
-
Clonal hematopoiesis is associated with adverse outcomes in patients with COVID-19
Study
EGAS00001006218
-
Scalable whole-genome single-cell library preparation without pre-amplification
Study
EGAS00001002170
-
DERMATLAS__SG_basal_cell_adenoma_and_adenocarcinoma_RNAseq
Study
EGAS00001007746
-
Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia
Study
EGAS00001001926
-
Sequencing_component_for_the_whole_genome_methylation_analysis_in_PBMCs_and_cell_subsets__pilot_study_
Study
EGAS00001000490
-
Genetic_mechanisms_of_resistance_to_chemotherapy_in_breast_cancer
Study
EGAS00001000276
-
MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells
Study
EGAS00001001199
-
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
Study
EGAS00001005023
-
Epigenome and transcriptome profiling of chronic lymphocytic leukemia patients
Study
EGAS00001001821
-
The ICGC-TCGA DREAM Somatic Mutation Calling - Tumour Heterogeneity Challenge
Study
EGAS00001002092
-
WGS of T-cell and NK-cell lymphoma for ICGC (NKTL-SG)
Study
EGAS00001002398
-
DERMATLAS__Porocarcinoma_WES
Study
EGAS00001005720
-
DERMATLAS__Porocarcinoma_RNAseq
Study
EGAS00001005721
-
Somatic_mutation_profiling_of_intestinal_crypts_from_IBD
Study
EGAS00001002896
-
DERMATLAS__Poroma_RNAseq
Study
EGAS00001005759
-
Molecular origins of mpMRI visibility
Study
EGAS00001003179
-
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis
Study
EGAS00001004373
-
Functional and genomic heterogeneity of long-term self-renewing compartment as the origin of treatment resistance in pancreatic tumors
Study
EGAS00001003442
-
DERMATLAS__Poroma_WES
Study
EGAS00001007705
-
DERMATLAS__SG_basal_cell_adenoma_and_adenocarcinoma_WES
Study
EGAS00001007745
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Women's Health Initiative Clinical Trial and Observational Study
Study
phs000200
-
PAK4 inhibition improves PD-1 blockade immunotherapy
Study
phs001919
-
Correlative Genomic Analysis of Durvalumab plus Pazopanib Combination in Patients with Advanced Soft Tissue Sarcomas
Study
EGAS50000000082
-
Stand Up 2 Cancer (SU2C) Genomics-Enabled Medicine for Melanoma (GEMM) Trial
Study
phs001786